Analysts Point To Mimedx Group Inc (NASDAQ: MDXG) Growth In The Future

After Hours

There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Stocks Info

As a NASDAQ listed company, MDXG falls under the Healthcare sector while operating within the Biotechnology industry segment. The current market capitalization of Mimedx Group Inc is $930.26M. A total of 0.88 million shares were traded on the day, compared to an average of 777.30K shares.

In the most recent transaction, Hulse William Frank IV sold 20,381 shares of MDXG for 7.95 per share on Mar 13 ’24. After the transaction, the General Counsel and CAO now owns 479,959 company shares. In a previous transaction on Feb 20 ’24, Whitlow Ricci S sold 15,271 shares at 8.01 per share. MDXG shares that Chief Operating Officer owns now total 401,050.

Among the insiders who sold shares, Whitlow Ricci S disposed of 15,493 shares on Feb 16 ’24 at a per-share price of $8.07. This resulted in the Chief Operating Officer holding 416,321 shares of MDXG after the transaction. In another insider transaction, Whitlow Ricci S sold 15,198 shares at $8.06 per share on Feb 15 ’24. Company shares held by the Chief Operating Officer now total 431,814.

In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. In terms of 52-week highs and lows, MDXG has a high of $9.27 and a low of $3.31.

As of this writing, MDXG has an earnings estimate of $MiMedx Group, Inc per share for the current quarter. EPS was calculated based on a consensus of MDxHealth SA estimates, with a high estimate of $SPDR S&P 400 Mid Cap Growth ETF per share and a lower estimate of $Interpace Biosciences, Inc..

Balance Sheet Annually/Quarterly

The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. MDXG’s latest balance sheet shows that the firm has $87.08M in Cash & Short Term Investments as of fiscal 2021. There were $48.13M in debt and $42.36M in liabilities at the time. Its Book Value Per Share was $0.98, while its Total Shareholder’s Equity was $82.00k.

Analysts Opinion

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for MDXG is Buy with a score of 5.00.

Most Popular

Related Posts